Content Type: Commentary & Opinion

Removing ERISA’s Impediment to State Health Reform

March 16, 2026

Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine

March 16, 2026

Regulatory Decision-Making on COVID-19 Vaccines During a Public Health Emergency

March 16, 2026

The Supreme Court, Preemption, and Malpractice Liability

March 16, 2026

The Supreme Court’s Latest Ruling on Drug Liability and Its Implications for Future Failure-To-Warn Litigation

March 16, 2026

Gene Patenting—The Supreme Court Finally Speaks

March 16, 2026

Biomarkers Unbound—The Supreme Court’s Ruling on Diagnostic-Test Patents

March 16, 2026

The Supreme Court Ruling in Sandoz v. Amgen: A Victory for Follow-On Biologics

March 16, 2026

Legal Challenges to State Drug Pricing Laws

March 16, 2026

The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines

March 16, 2026

Recent Orange and Purple Book Legislation Suggests a Need to Bridge Drug and Biologic Patent Regimes

March 16, 2026

The Future of Drug-Pricing Transparency

March 16, 2026